U.S. Semiconductors Stock News

In recent updates, Celldex Therapeutics reported progression of its antibody pipeline, including global Phase 3 trials for barzolvolimab in chronic urticarias and early-stage data for bispecific antibody CDX-622. A key insight for investors is Celldex’s cash runway reportedly extending through 2027, supporting continued development of these late- and mid-stage programs. Next, we’ll explore how this pipeline momentum, particularly the Phase 3 barzolvolimab program, shapes Celldex...

Why the latest earnings report matters for AdaptHealth AdaptHealth (AHCO) recently reported quarterly revenue of US$820.3 million, which came in 2.5% above analyst estimates, with full year guidance aligned to market expectations despite slower growth compared with peers. This mix of modest outperformance and steady guidance has drawn fresh attention to the stock as investors weigh how a slower growing home medical equipment provider fits into a sector facing labor cost and reimbursement...

Over the past year, Inspire Medical Systems has faced multiple class action lawsuits alleging it misled investors about demand, preparedness, and execution for its Inspire V next‑generation sleep apnea device launch, alongside operational rollout issues highlighted by at least one institutional investor exiting its position. These legal challenges and execution concerns sit in sharp contrast to prior enthusiasm about Inspire’s technology, underscoring how operational follow-through and...

If you are wondering whether EVERTEC at around US$30.17 is offering value right now, you are not alone. This article is built to help you weigh what that price might really mean. The stock has returned 5.2% over the last 7 days and 1.5% over the last 30 days, while year to date it is up 5.2%. However, its 1 year, 3 year and 5 year returns of 4.5%, 11.1% and 19.3% declines tell a different story. Recent attention on EVERTEC has been shaped more by its share price history and sector sentiment...

Jack Henry & Associates (JKHY) is back in focus after a cluster of analyst upgrades and a fresh core banking deal with Sanibel Captiva Community Bank, putting its fintech franchise under renewed investor scrutiny. See our latest analysis for Jack Henry & Associates. The recent core banking win with Sanibel Captiva Community Bank and a wave of analyst upgrades have coincided with a 24.29% 90 day share price return and an 11.46% 1 year total shareholder return, pointing to momentum that...

Nomad Foods recently outlined a plan to streamline its operations between 2026 and 2028 targeting US$200 million in cost savings, while continuing share repurchases and maintaining a dividend yield of 5.8% supported by current earnings. Insider share purchases at decade-low valuation levels, alongside consistent free cash flow generation and ongoing buybacks that have reduced the share count by about 4% annually since 2021, underline management’s confidence in the business. We’ll now examine...

With a price-to-earnings (or "P/E") ratio of 27.9x Veralto Corporation ( NYSE:VLTO ) may be sending bearish signals at...

Atmus Filtration Technologies Inc. ( NYSE:ATMU ), might not be a large cap stock, but it received a lot of attention...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Key Insights The considerable ownership by individual investors in GrabAGun Digital Holdings indicates that they...

Despite an already strong run, GSI Technology, Inc. ( NASDAQ:GSIT ) shares have been powering on, with a gain of 37% in...

While Formula One Group ( NASDAQ:FWON.K ) shareholders are probably generally happy, the stock hasn't had particularly...

You may think that with a price-to-sales (or "P/S") ratio of 1.1x Karyopharm Therapeutics Inc. ( NASDAQ:KPTI ) is...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Key Insights The projected fair value for OKYO Pharma is US$4.58 based on 2 Stage Free Cash Flow to Equity Current...

Ultra Clean Holdings, Inc. ( NASDAQ:UCTT ) shares have had a really impressive month, gaining 31% after a shaky period...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Some stocks are best avoided. We don't wish catastrophic capital loss on anyone. Anyone who held Cryoport, Inc...

Kronos Worldwide, Inc.'s ( NYSE:KRO ) price-to-sales (or "P/S") ratio of 0.3x may look like a pretty appealing...

Some Flowers Foods, Inc. ( NYSE:FLO ) shareholders may be a little concerned to see that the CEO & Chairman of Board...

The board of Richardson Electronics, Ltd. ( NASDAQ:RELL ) has announced that it will pay a dividend of $0.06 per share...

If you are wondering whether National Vision Holdings is still good value after its recent run, looking closely at what the current share price implies can help you set realistic expectations. The stock last closed at US$26.34, with returns of 1.5% over the past week, an 8.6% decline over the past 30 days, 1.5% year to date, a 150.4% gain over the past year, a 35.0% decline over three years, and a 45.8% decline over five years. This combination paints a mixed picture for anyone thinking...

Monarch Casino & Resort (MCRI) is back on traders’ radar after a recent pullback, with the stock down about 6% over the past month and modestly lower over the past 3 months. See our latest analysis for Monarch Casino & Resort. Zooming out a bit, the recent 1 month share price return of a 5.88% decline sits against a 1 year total shareholder return of 20.43%. This suggests that shorter term momentum has faded, while longer term holders have still seen gains. If Monarch Casino & Resort’s recent...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...